Outcomes of Eyes Lost to Follow-Up With Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation vs Intravitreal Anti-Vascular Endothelial Growth Factor

Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2018.07.027
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Elsevier BV

Related search

Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy

2010English

Cost Evaluation of Panretinal Photocoagulation Versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy

Ophthalmology
Ophthalmology
2016English

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy With New Dense Vitreous Hemorrhage After Full Panretinal Photocoagulation

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2013English

Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Archives of Ophthalmology
2006English

Upregulated Expression of Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1996English

Evaluation of Visual Outcome in Proliferative Diabetic Retinopathy After Panretinal Photocoagulation

Journal of Evolution of Medical and Dental Sciences
2019English

Vascular Endothelial Growth Factor Inhibition for Proliferative Diabetic Retinopathy: Et Tu, Brute?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy

JAMA Ophthalmology
Ophthalmology
2017English

Pain Relief During Panretinal Photocoagulation for Diabetic Retinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy